Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NCPAP + Heliox as a Treatment for Infant Respiratory Distress Syndrome (RDS)

NCT01383850 is registered in ClinicalTrials.gov with Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico as lead sponsor.

NCT NCT01383850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01383850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NCPAP + Heliox as a Treatment for Infant Respiratory Distress Syndrome (RDS)
Lead sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2008
Completion date
September 30, 2010
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia, respiratory distress syndrome